The invention discloses a combined general check
protein chip for early-stage cancers mainly comprising
lung cancer and belongs to the technical field of a
protein chip. The combined general check
protein chip for the early-stage cancers mainly comprising the
lung cancer, provided by the invention, comprises a chip substrate and marker antibodies distributed on the chip substrate, wherein the chip substrate is an FAST
protein chip substrate having a three-dimensional
nitrocellulose basic material; one or more sample
application module is arranged on the FAST
protein chip substrate; the following marker antibodies are fixed on the sample
application module: 14-3-3 theta, LAMR-1, TSGF (
Tumor Specific Growth Factor), CEA (
Cancer Embryo Antigen), SCC (Squamous
Cell Carcinoma), CYFRA21-1 and
positive control; the following marker antibodies are also fixed: AFP (Alpha
Fetal Protein), CA242, MG-Ag, CA199, TPA (Tissue Polypeptide
Antigen) and EA-IgA; and the following marker antibodies are further fixed: CA125, CA153, SF (Serum
Ferritin) and PSA (
Prostate Specific
Antigen). According to the combined general check
protein chip provided by the invention, the related indexes are highly integrated; the combined general check protein chip has the advantages of excellent stability, strong specificity, long
retention period, high sensitivity, excellent
repeatability, convenience in operation and low cost; the labor efficiency is increased; and a
cancer patient is diagnosed and treated from the general check before clinical symptoms occur.